- Home
- ZBIO vs BRIA Comparison
ZBIO vs BRIA Comparison
Compare ZBIO & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- BRIA
- Stock Information
- Founded
- ZBIO 2019
- BRIA 2011
- Country
- ZBIO United States
- BRIA Singapore
- Employees
- ZBIO N/A
- BRIA N/A
- Industry
- ZBIO
- BRIA
- Sector
- ZBIO
- BRIA
- Exchange
- ZBIO NYSE
- BRIA NYSE
- Market Cap
- ZBIO 389.2M
- BRIA 62.0M
- IPO Year
- ZBIO 2024
- BRIA 2024
- Fundamental
- Price
- ZBIO $11.18
- BRIA $2.38
- Analyst Decision
- ZBIO Strong Buy
- BRIA
- Analyst Count
- ZBIO 7
- BRIA 0
- Target Price
- ZBIO $32.29
- BRIA N/A
- AVG Volume (30 Days)
- ZBIO 175.9K
- BRIA 2.8K
- Earning Date
- ZBIO 08-16-2025
- BRIA 08-15-2025
- Dividend Yield
- ZBIO N/A
- BRIA N/A
- EPS Growth
- ZBIO N/A
- BRIA N/A
- EPS
- ZBIO N/A
- BRIA 92.24
- Revenue
- ZBIO $15,000,000.00
- BRIA $59,695,825.00
- Revenue This Year
- ZBIO $206.00
- BRIA N/A
- Revenue Next Year
- ZBIO $41.92
- BRIA N/A
- P/E Ratio
- ZBIO N/A
- BRIA $0.03
- Revenue Growth
- ZBIO N/A
- BRIA 8.03
- 52 Week Low
- ZBIO $5.83
- BRIA $1.78
- 52 Week High
- ZBIO $26.25
- BRIA $4.38
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- BRIA N/A
- Support Level
- ZBIO N/A
- BRIA N/A
- Resistance Level
- ZBIO N/A
- BRIA N/A
- Average True Range (ATR)
- ZBIO 0.00
- BRIA 0.00
- MACD
- ZBIO 0.00
- BRIA 0.00
- Stochastic Oscillator
- ZBIO 0.00
- BRIA 0.00
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.